For: | Kagawa S, Shigeyasu K, Ishida M, Watanabe M, Tazawa H, Nagasaka T, Shirakawa Y, Fujiwara T. Molecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patients. World J Gastroenterol 2014; 20(47): 17796-17803 [PMID: 25548478 DOI: 10.3748/wjg.v20.i47.17796] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i47/17796.htm |
Number | Citing Articles |
1 |
M. Miró, R. Vives, L. Farran, L. Secanella, M. Varela, N. Baixeras, F. Estremiana, C. Bettonica, H. Aranda, M. Galán. Utility of Molecular Analysis of Peritoneal Fluid in Staging Laparoscopy of Advanced Esophagogastric Junction and Gastric Cancer Prior to Neoadjuvant Treatment. Journal of Gastrointestinal Cancer 2023; 54(2): 651 doi: 10.1007/s12029-022-00846-8
|
2 |
Jianbo Xiong, Zhengrong Li, Yang Zhang, Daojiang Li, Guoyang Zhang, Xianshi Luo, Zhigang Jie, Yi Liu, Yi Cao, Zhibiao Le, Shengxing Tan, Wenyu Zou, Peitao Gong, Lingyu Qiu, Yuanyuan Li, Huan Wang, Heping Chen. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN. Oncology Reports 2016; 36(4): 1819 doi: 10.3892/or.2016.5030
|
3 |
Xun Chen, Zhouqiao Wu, Yexuan He, Zhe Hao, Qi Wang, Keji Zhou, Wanhui Zhou, Pu Wang, Fei Shan, Zhongwu Li, Jiafu Ji, Yubo Fan, Ziyu Li, Shuhua Yue. Accurate and Rapid Detection of Peritoneal Metastasis from Gastric Cancer by AI‐Assisted Stimulated Raman Molecular Cytology. Advanced Science 2023; 10(21) doi: 10.1002/advs.202300961
|
4 |
Yanjun Hou, Frido K. Bruehl, Kelsey E. McHugh, Jordan P. Reynolds. Primary tumor types and origins in positive abdominopelvic washing cytology, a single institution experience. Journal of the American Society of Cytopathology 2020; 9(2): 89 doi: 10.1016/j.jasc.2019.10.001
|
5 |
Yanyan Chen, Quan Zhou, Haiyong Wang, Wei Zhuo, Yongfeng Ding, Jun Lu, Guanghao Wu, Nong Xu, Lisong Teng. Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers. Cancers 2020; 12(8): 2236 doi: 10.3390/cancers12082236
|
6 |
Yuanbo Li, Yan Sun, Zhenlu Li, Shikuan Li, Changliang Wu, Enas Abdulhay. MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/4033373
|
7 |
Yongjun Zhang, Shuguang Guo, Jian Fang, Bojian Peng, Yuan Zhang, Tiansheng Cao. Tanshinone IIA inhibits cell proliferation and tumor growth by downregulating STAT3 in human gastric cancer. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6562
|
8 |
Jia‑Jun Wang, Yu‑Chong Yang, Yong‑Xi Song, Peng Gao, Jing‑Xu Sun, Xiao‑Wan Chen, Bin Ma, Zhen‑Ning Wang. Long non‑coding RNA AB007962 is downregulated in gastric cancer and associated with poor prognosis. Oncology Letters 2018; doi: 10.3892/ol.2018.9169
|
9 |
Hexiao Wang, Lei Hu, Mingde Zang, Baogui Zhang, Yantao Duan, Zhiyuan Fan, Jianfang Li, Liping Su, Min Yan, Zhenggang Zhu, Bingya Liu, Qiumeng Yang. REG4 promotes peritoneal metastasis of gastric cancer through GPR37. Oncotarget 2016; 7(19): 27874 doi: 10.18632/oncotarget.8442
|
10 |
Weizhao Peng, Shuang Si, Qingxia Zhang, Chaofeng Li, Fang Zhao, Fang Wang, Jia Yu, Ren Ma. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0197-7
|
11 |
Changming Wang, Jiapeng Xu, Hongbing Fu, Yu Zhang, Xin Zhang, Dejun Yang, Zhenxin Zhu, Ziran Wei, Zunqi Hu, Ronglin Yan, Qingping Cai. TRIM32 promotes cell proliferation and invasion by activating β‐catenin signalling in gastric cancer. Journal of Cellular and Molecular Medicine 2018; 22(10): 5020 doi: 10.1111/jcmm.13784
|
12 |
H.H. Rashwan, A.M. Taher, H.A. Hassan, A.A. Awaji, C.J. Kiriacos, R.A. Assal, R.A. Youness. Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies. Pathology - Research and Practice 2024; 256: 155223 doi: 10.1016/j.prp.2024.155223
|
13 |
Meizhong Xu, Shui Qin, Fan Cao, Shi Ding, Mengnan Li. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer. International Journal of Oncology 2017; 51(3): 867 doi: 10.3892/ijo.2017.4072
|
14 |
Karol Polom, Luigi Marano, Giandomenico Roviello, Roberto Petrioli, Riccardo Piagnerelli, Lorenzo de Franco, Daniele Marrelli, Franco Roviello. Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence. International Journal of Hyperthermia 2016; 32(2): 173 doi: 10.3109/02656736.2015.1111432
|
15 |
Yanhua Li, Junjiao Gu, Hong Lu. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway. Digestive Diseases and Sciences 2017; 62(12): 3426 doi: 10.1007/s10620-017-4831-4
|
16 |
Katarzyna Gęca, Magdalena Skórzewska, Karol Rawicz-Pruszyński, Radosław Mlak, Katarzyna Sędłak, Zuzanna Pelc, Teresa Małecka-Massalska, Wojciech P. Polkowski. Prognostic value of molecular cytology by one-step nucleic acid amplification (OSNA) assay of peritoneal washings in advanced gastric cancer patients. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-16761-8
|
17 |
Hongkui Yang, Wenjun Xu. STAT3 promotes peritoneal metastasis of gastric cancer by enhancing mesothelial-mesenchymal transition. Biological Chemistry 2021; 402(6): 739 doi: 10.1515/hsz-2021-0120
|
18 |
Megumi Watanabe, Shunsuke Kagawa, Kazuya Kuwada, Yuuri Hashimoto, Kunitoshi Shigeyasu, Michihiro Ishida, Shuichi Sakamoto, Atene Ito, Satoru Kikuchi, Shinji Kuroda, Hiroyuki Kishimoto, Shuta Tomida, Ryuichi Yoshida, Hiroshi Tazawa, Yasuo Urata, Toshiyoshi Fujiwara. Integrated fluorescent cytology with nano‐biologics in peritoneally disseminated gastric cancer. Cancer Science 2018; 109(10): 3263 doi: 10.1111/cas.13760
|
19 |
Junjie Zhao, Ruihuan Qin, Hao Chen, Yupeng Yang, Wenjun Qin, Jing Han, Xuefei Wang, Shifang Ren, Yihong Sun, Jianxin Gu. A nomogram based on glycomic biomarkers in serum and clinicopathological characteristics for evaluating the risk of peritoneal metastasis in gastric cancer. Clinical Proteomics 2020; 17(1) doi: 10.1186/s12014-020-09297-4
|
20 |
思颖 朱. The Diagnosis and Treatment of Peritoneal Metastasis of Gastric Cancer. Advances in Clinical Medicine 2021; 11(01): 99 doi: 10.12677/ACM.2021.111014
|
21 |
Xiaowen Liu, Ziwen Long, Hong Cai, Shengjia Yu, Jianghong Wu. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination. Cancer Biology & Therapy 2020; 21(3): 203 doi: 10.1080/15384047.2019.1679554
|
22 |
Zhenya Zhu, Yong Wang, Chunhui Zhang, Shiyong Yu, Qi Zhu, Kun Hou, Bo Yan. RETRACTED ARTICLE: TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling. Scientific Reports 2016; 6(1) doi: 10.1038/srep19070
|
23 |
Joanna K.M. Ng, Lok Hang Chow, Annabelle M.Y. Ngai, Ronald C.K. Chan, Jacqueline H.S. Lee, Alfred L.H. Lee, Joshua J.X. Li, Curtis C.K. To, Gary M. Tse. Number Needed to Diagnose in Malignant Ascites: Effects of Volume, Repeating Collection, and Primary Malignancy on Diagnostic Performance in Peritoneal Fluid Cytology. Acta Cytologica 2023; 67(4): 434 doi: 10.1159/000529855
|